Related Experiment Video
Updated: Jul 4, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
Enhanced L-arginine-induced vasoreactivity suggests endothelial dysfunction in CADASIL
Nils Peters1, Tobias Freilinger, Christian Opherk
1Dept. of Neurology, Klinikum Grosshadern, Ludwig-Maximilians-University, Marchioninistrasse 15, 81377, Munich, Germany. Nils.Peters@med.uni-muenchen.de
Cerebral artery function is impaired in Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL). Enhanced L-arginine vasoreactivity suggests potential therapeutic strategies for CADASIL and small vessel diseases.
Area of Science:
- Neurology
- Vascular Biology
- Genetics
Background:
- Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is caused by Notch3 gene mutations, leading to stroke and dementia.
- Pathological hallmarks include arterial granular deposits and smooth muscle cell degeneration.
- Endothelial function in CADASIL remains poorly understood, despite its importance in cerebrovascular health.
Purpose of the Study:
- To assess endothelial function in CADASIL patients by measuring L-arginine-induced vasoreactivity.
- To compare cerebral hemodynamic parameters between CADASIL patients and healthy controls.
Main Methods:
- Transcranial Doppler sonography was used to measure middle cerebral artery blood flow velocity and pulsatility index.
- L-arginine, a substrate for nitric oxide synthase, was administered to assess endothelial-dependent vasoreactivity.
- 25 CADASIL patients and 24 non-CADASIL controls were included.
Main Results:
- CADASIL patients showed reduced resting mean flow velocity and increased pulsatility index compared to controls.
- L-arginine administration significantly increased vasoreactivity in CADASIL patients compared to controls.
- A significant reduction in pulsatility index was observed after L-arginine in CADASIL patients, indicating improved vasodilation.
Conclusions:
- Impaired cerebral hemodynamics and endothelial dysfunction likely play a pathogenic role in CADASIL.
- The enhanced L-arginine vasoreactivity in CADASIL suggests potential therapeutic targets.
- Findings may offer insights into treating sporadic small vessel diseases as well.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Nitric Oxide Signaling Pathway
Antihypertensive Drugs: Vasodilators
Coronary Artery Disease II: Pathophysiology
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Coronary Artery Disease I: Introduction
